Category: Business

Riassunto: NOVALIQ rafforza il team dirigenziale con la nomina a direttore medico della dottoressa Gabriela Burian, MPH

HEIDELBERG, Germania–(BUSINESS WIRE)–NOVALIQ GmbH, società farmaceutica con una piattaforma di distribuzione di farmaci totalmente innovativa in grado di trasformare medicinali scarsamente solubili in terapie oftalmiche efficaci, ha oggi annunciato la nomina della dottoressa Gabriela Burian, MPH, a direttore medico (CMO) di NOVALIQ. La dottoressa Burian vanta un’esperienza più che venticinquennale nel settore clinico internazionale. È responsabile dello sviluppo clinico globale e dell’attivit

Vital Art and Science Announces License Agreement with Genentech for Its mVT® Service

DALLAS–(BUSINESS WIRE)–Vital Art and Science, LLC today announced that it has signed a license agreement with Genentech, a member of the Roche Group, for the use of Vital Art and Science’s mVT® App service in Genentech’s ophthalmology clinical studies. Under the terms of the agreement, Genentech intends to use the App service to enhance patient experience, improve the effectiveness of patient‘s interactions with health care providers and apply the data collected through the App service to imp

National Vision Announces Recipients of 2017 College Scholarship Program

DULUTH, Ga.–(BUSINESS WIRE)–National Vision Inc., one of the nation’s largest optical retailers, today announced it has awarded five high school seniors as recipients of the 2017 National Vision College Scholarship Program. Each student will receive $2,500 to support their upcoming college education, and the awards are renewable up to three years for a total scholarship of up to $10,000 per student. “We are incredibly honored to support the continued education of these outstanding, bright stu

Teva Announces Exclusive Launch of Generic Pataday® in the United States

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of generic Pataday®1 (olopatadine hydrochloride ophthalmic solution) 0.2%, in the U.S. Olopatadine hydrochloride ophthalmic solution 0.2% is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis. Teva is committed to strengthening its generics business through continued investment in complex, high-quality products. With nearly 6

Global Fundus Camera Market (2017-2021) – Expected to Grow to Us$ 788.7 Million By 2021 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Fundus Camera Market Assessment & Forecast: 2017 – 2021” report to their offering. Fundus camera market has been majorly concentrated in North America region and has now reached near saturation. With increasing penetration in rural areas and support from gradual developing healthcare sector, developing countries would witness faster growth throughout the forecast period. Currently North America accounts

Global Single Use Contact Lenses Market – Industry Forecast to 2025 – Increasing Rate of Ophthalmologic & Uncorrected Refracted Eye Error – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Single Use Contact Lenses Market Analysis & Trends – Industry Forecast to 2025” report to their offering. The Global Single Use Contact Lenses Market report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and foreca